BCTG Acquisition Corp. (BCTG)
Stock Price: $11.40 USD
0.45 (4.11%)
Updated Jun 15, 2021 4:00 PM EDT - Market closed
| Market Cap | 234.29M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Shares Out | 21.38M |
| EPS (ttm) | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | June 15 |
| Last Price | $11.40 |
| Previous Close | $10.95 |
| Change ($) | 0.45 |
| Change (%) | 4.11% |
| Day's Open | 10.96 |
| Day's Range | 11.00 - 11.40 |
| Day's Volume | 2,600 |
| 52-Week Range | 9.83 - 14.00 |
News
Tango Therapeutics, a biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, and BCTG Acquisition Corp. (Nasdaq: BCTG), a special purpose acquis...
About BCTG
BCTG Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses primarily located in North America and Europe in the biotechnology industry. The company was incorporated in 2020 and is based in San Diego, California.
| Industry Shell Companies | IPO Date Sep 3, 2020 |
| Stock Exchange NASDAQ | Ticker Symbol BCTG |